01. The $1Trillion Upside Is Made of Small Fixes
A trillion dollars is not one breakthrough product. It is thousands of everyday problems caught earlier: conditions treated before they snowball, symptoms taken seriously before they become chronic, care delivered before it turns into a hospital bill.
When women’s health improves, workforce participation rises, families stabilise, and public systems face fewer late-stage interventions.
Source: McKinsey (2023)
02. The UK’s £11bn Leak Happens in Plain Sight
£11 billion a year is what it looks like when health problems are pushed down the road: repeated appointments, delayed diagnoses, unmanaged menopause, persistent pain, time lost in drips.
The cost isn’t dramatic. It is constant. It lands on payrolls, on sick leave, on retention, and on the invisible work people do to keep functioning.
Source: NHS Confederation (2024)
03. $1-to-$20 Returns: The Motherhood Multiplier
Maternal and child health is a long arc investment. Better maternal care reduces complications and long-term morbidity.
It also shapes childhood outcomes, education trajectories and household stability.
That is why the return is so high: you are not buying a single moment of care, you are changing the baseline for a family.
Source: World Economic Forum (2023)
04. £1-to-£11: OB/GYN as Throughput Strategy
Investing in OB/GYN services buys back system capacity. It reduces the expensive part of the curve: advanced disease, emergency admissions, and avoidable escalation.
For investors, that’s the point. This is how healthcare stops reacting and starts controlling flow.
Source: NHS Confederation (2024)
05. 300% VC Surge: Capital Is Following the Maths
Women’s health funding has surged since 2018 because the opportunity is no longer a vague social case.
The data is clear, the exits are real, and the unmet need is visible across public and private systems. When an area is underfunded for decades, the correction does not arrive politely.
Source: City AM (2024)
